Guo XQ - Search Results

1

Integrative topological analysis of mass spectrometry data reveals molecular features with clinical relevance in esophageal squamous cell carcinoma.

Gao SG, Liu RM, Zhao YG, Wang P, Ward DG, Wang GC, Guo XQ, Gu J, Niu WB, Zhang T, Martin A, Guo ZP, Feng XS, Qi YJ, Ma YF. Gao SG, et al. Among authors: guo zp, guo xq. Sci Rep. 2016 Feb 22;6:21586. doi: 10.1038/srep21586. Sci Rep. 2016. PMID: 26898710 Free PMC article.

2

Distinct esophageal adenocarcinoma molecular subtype has subtype-specific gene expression and mutation patterns.

Guo X, Tang Y, Zhu W. Guo X, et al. BMC Genomics. 2018 Oct 24;19(1):769. doi: 10.1186/s12864-018-5165-0. BMC Genomics. 2018. PMID: 30355311 Free PMC article.

3

Gene Expression Profiling Reveals Distinct Molecular Subtypes of Esophageal Squamous Cell Carcinoma in Asian Populations.

Wang F, Yan Z, Lv J, Xin J, Dang Y, Sun X, An Y, Qi Y, Jiang Q, Zhu W, Li Y, Li A, Guo X. Wang F, et al. Neoplasia. 2019 Jun;21(6):571-581. doi: 10.1016/j.neo.2019.03.013. Epub 2019 Apr 29. Neoplasia. 2019. PMID: 31048097 Free PMC article.

4

Identification of hub genes and pathways in adrenocortical carcinoma by integrated bioinformatic analysis.

Guo J, Gu Y, Ma X, Zhang L, Li H, Yan Z, Han Y, Xie L, Guo X. Guo J, et al. J Cell Mol Med. 2020 Apr;24(8):4428-4438. doi: 10.1111/jcmm.15102. Epub 2020 Mar 8. J Cell Mol Med. 2020. PMID: 32147961 Free PMC article.

5

Porphyromonas gingivalis promotes progression of esophageal squamous cell cancer via TGFβ-dependent Smad/YAP/TAZ signaling.

Qi YJ, Jiao YL, Chen P, Kong JY, Gu BL, Liu K, Feng DD, Zhu YF, Ruan HJ, Lan ZJ, Liu QW, Mi YJ, Guo XQ, Wang M, Liang GF, Lamont RJ, Wang H, Zhou FY, Feng XS, Gao SG. Qi YJ, et al. Among authors: guo xq. PLoS Biol. 2020 Sep 4;18(9):e3000825. doi: 10.1371/journal.pbio.3000825. eCollection 2020 Sep. PLoS Biol. 2020. Retraction in: PLoS Biol. 2022 Apr 15;20(4):e3001617. doi: 10.1371/journal.pbio.3001617 PMID: 32886690 Free PMC article. Retracted.

6

Comprehensive analysis of lncRNAs as biomarkers for diagnosis, prognosis, and treatment response in clear cell renal cell carcinoma.

Chao X, Wang P, Ma X, Li Z, Xia Y, Guo Y, Ge L, Tian L, Zheng H, Du Y, Li J, Zuo Z, Xie L, Guo X. Chao X, et al. Mol Ther Oncolytics. 2021 Aug 19;22:209-218. doi: 10.1016/j.omto.2021.08.003. eCollection 2021 Sep 24. Mol Ther Oncolytics. 2021. PMID: 34514100 Free PMC article.

7

Identification of distinct molecular subtypes of uterine carcinosarcoma.

An Y, Wang H, Jie J, Tang Y, Zhang W, Ji S, Guo X. An Y, et al. Oncotarget. 2017 Feb 28;8(9):15878-15886. doi: 10.18632/oncotarget.15032. Oncotarget. 2017. PMID: 28178664 Free PMC article.

8

Distinct molecular subtypes of uterine leiomyosarcoma respond differently to chemotherapy treatment.

An Y, Wang S, Li S, Zhang L, Wang D, Wang H, Zhu S, Zhu W, Li Y, Chen W, Ji S, Guo X. An Y, et al. BMC Cancer. 2017 Sep 11;17(1):639. doi: 10.1186/s12885-017-3568-y. BMC Cancer. 2017. PMID: 28893210 Free PMC article.

9

OSuvm: An interactive online consensus survival tool for uveal melanoma prognosis analysis.

Wang F, Wang Q, Li N, Ge L, Yang M, An Y, Zhang G, Dong H, Ji S, Zhu W, Guo X. Wang F, et al. Mol Carcinog. 2020 Jan;59(1):56-61. doi: 10.1002/mc.23128. Epub 2019 Oct 23. Mol Carcinog. 2020. PMID: 31646691

10

OSpaad: An online tool to perform survival analysis by integrating gene expression profiling and long-term follow-up data of 1319 pancreatic carcinoma patients.

Zhang G, Wang Q, Yang M, Yao X, Qi X, An Y, Dong H, Zhang L, Zhu W, Li Y, Guo X. Zhang G, et al. Mol Carcinog. 2020 Mar;59(3):304-310. doi: 10.1002/mc.23154. Epub 2020 Jan 8. Mol Carcinog. 2020. PMID: 31912599

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

278 results

Search Page

Filters